{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:02:29Z","timestamp":1785427349636,"version":"3.56.0"},"reference-count":45,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Aromatase inhibitors (AIs) profoundly suppress estrogen synthesis and accelerate bone loss in postmenopausal women with early breast cancer (EBC). Although body mass index (BMI)\u2013defined obesity has been considered protective for skeletal health, emerging evidence suggests a paradoxical association with fracture risk.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate whether fat mass percentage (FM%) greater than 40.8%, measured by dual-energy x-ray absorptiometry (DXA), is associated with vertebral fracture (VF) progression in patients with EBC receiving AIs.<\/jats:p>\n <\/jats:sec>\n \n Design, Settings, and Participants<\/jats:title>\n This retrospective cohort study included consecutive postmenopausal women with EBC (stages I-III) recruited in a single referral center between September 2014 and June 2024. All patients received adjuvant endocrine therapy and underwent serial DXA assessments. Patients treated with tamoxifen or with major comorbidities affecting skeletal fragility were excluded.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Body composition and bone fragility parameters evaluated by DXA at baseline and at 18, 24, and 30 months.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Adiposity excess was defined as FM% greater than 40.8%, and VF progression was defined as new incident fractures and\/or worsening by at least 1 Genant grade at a previously fractured vertebral level. Their association was evaluated using a joint model; time-dependent associations were evaluated using extended Cox regression. Secondary analyses explored associations with bone mineral density, trabecular bone score (TBS), appendicular lean mass index (ALMI), and traditional fracture risk factors.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A total of 769 White women (median [range] age, 63 [30-87] years; median [range] BMI, 24.6 [15.6-46.1]) entered the study. During follow-up, 69 patients (9.0%) experienced VF progression. FM% greater than 40.8% was independently associated with increased VF progression (adjusted hazard ratio [HR], 2.00; 95% CI, 1.44-2.82;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). Higher ALMI (HR, 0.38; 95% CI, 0.22-0.65;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001) and BMD (HR, 0.79; 95% CI, 0.66-0.94;\n P<\/jats:italic>\n \u2009=\u2009.01) were associated with lower risk of VF progression.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this retrospective cohort study of patients with EBC receiving AIs, adiposity excess was identified as a novel fracture risk factor, whereas higher muscle mass was protective. These findings support incorporating body-composition assessment into fracture-risk evaluation and preventive strategies for patients undergoing AI therapy.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.26450","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:30:26Z","timestamp":1785425426000},"page":"e2626450","source":"Crossref","is-referenced-by-count":0,"title":["Adiposity Excess and Vertebral Fractures in Patients With Breast Cancer Taking Aromatase Inhibitors"],"prefix":"10.1001","volume":"9","author":[{"given":"Greta","family":"Schivardi","sequence":"first","affiliation":[{"name":"Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health (DSMC), University of Brescia, Brescia, Italy"},{"name":"Medical Oncology Unit, ASST Spedali Civili di Brescia Comprehensive Cancer Center, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Cosentini","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health (DSMC), University of Brescia, Brescia, Italy"},{"name":"Medical Oncology Unit, ASST Spedali Civili di Brescia Comprehensive Cancer Center, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Scartabellati","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health (DSMC), University of Brescia, Brescia, Italy"},{"name":"Medical Oncology Unit, ASST Spedali Civili di Brescia Comprehensive Cancer Center, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ravanelli","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health (DSMC), University of Brescia, Brescia, Italy"},{"name":"Diagnostic Radiology Unit 2, ASST Spedali Civili di Brescia Comprehensive Cancer Center, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Moretti","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health (DSMC), University of Brescia, Brescia, Italy"},{"name":"Medical Oncology Unit, ASST Spedali Civili di Brescia Comprehensive Cancer Center, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gherardo","family":"Mazziotti","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Italy"},{"name":"Metabolic Bone Diseases and Osteoporosis Section, IRCCS Humanitas Clinical and Research Hospital, Rozzano-Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Bazzoli","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health (DSMC), University of Brescia, Brescia, Italy"},{"name":"Medical Oncology Unit, ASST Spedali Civili di Brescia Comprehensive Cancer Center, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Strazzeri","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health (DSMC), University of Brescia, Brescia, Italy"},{"name":"Medical Oncology Unit, ASST Spedali Civili di Brescia Comprehensive Cancer Center, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Delbarba","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, Unit of Endocrinology and Metabolism, University of Brescia, Brescia, Italy"},{"name":"Unit of Endocrinology and Andrology, ASST Spedali Civili di Brescia Comprehensive Cancer Center, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Grisanti","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health (DSMC), University of Brescia, Brescia, Italy"},{"name":"Medical Oncology Unit, ASST Spedali Civili di Brescia Comprehensive Cancer Center, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Lagan\u00e0","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health (DSMC), University of Brescia, Brescia, Italy"},{"name":"Medical Oncology Unit, ASST Spedali Civili di Brescia Comprehensive Cancer Center, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Turla","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, ASST Valle Camonica, Esine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele Dalla","family":"Chiara","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health (DSMC), University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Cappelli","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, Unit of Endocrinology and Metabolism, University of Brescia, Brescia, Italy"},{"name":"Unit of Endocrinology and Andrology, ASST Spedali Civili di Brescia Comprehensive Cancer Center, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Farina","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health (DSMC), University of Brescia, Brescia, Italy"},{"name":"Diagnostic Radiology Unit 2, ASST Spedali Civili di Brescia Comprehensive Cancer Center, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Calza","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Donato","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Specialties Radiological Sciences and Public Health, Unit of Hygiene, Epidemiology, and Public Health, University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Berruti","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health (DSMC), University of Brescia, Brescia, Italy"},{"name":"Medical Oncology Unit, ASST Spedali Civili di Brescia Comprehensive Cancer Center, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Pedersini","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, ASST Spedali Civili di Brescia Comprehensive Cancer Center, Brescia, Italy"},{"name":"Medical Oncology Department, SSVD Breast Unit, ASST Spedali Civili of Brescia Comprehensive Cancer Center, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"zoi260726r1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102445","article-title":"Tailoring adjuvant endocrine therapy in early breast cancer: when, how, and how long?","volume":"110","author":"Cucciniello","year":"2022","journal-title":"Cancer Treat Rev"},{"issue":"26","key":"zoi260726r2","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1056\/NEJMra1307118","article-title":"Systemic therapy for estrogen receptor\u2013positive, HER2-negative breast cancer.","volume":"383","author":"Burstein","year":"2020","journal-title":"N Engl J Med"},{"issue":"33","key":"zoi260726r3","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1200\/JCO.19.01472","article-title":"Use of endocrine therapy for breast cancer risk reduction: ASCO clinical practice guideline update.","volume":"37","author":"Visvanathan","year":"2019","journal-title":"J Clin Oncol"},{"issue":"9","key":"zoi260726r4","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/annonc\/mdp033","article-title":"Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial.","volume":"20","author":"Rabaglio","year":"2009","journal-title":"Ann Oncol"},{"key":"zoi260726r5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.bone.2017.01.013","article-title":"Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: a cross-sectional study.","volume":"97","author":"Pedersini","year":"2017","journal-title":"Bone"},{"issue":"5","key":"zoi260726r6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S2213-8587(24)00088-3","article-title":"Endocrine health in survivors of adult-onset cancer.","volume":"12","author":"Link-Rachner","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"zoi260726r7","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1007\/s00586-008-0753-3","article-title":"The course of the acute vertebral body fragility fracture: its effect on pain, disability and quality of life during 12 months.","volume":"17","author":"Suzuki","year":"2008","journal-title":"Eur Spine J"},{"issue":"5","key":"zoi260726r8","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1210\/jc.86.5.2263","article-title":"Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk.","volume":"86","author":"Masi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"zoi260726r9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.93224","article-title":"Hormonal changes during menopause and their impact on bone health: insights from orthopedic and reproductive medicine.","volume":"17","author":"Rasul","year":"2025","journal-title":"Cureus"},{"issue":"3","key":"zoi260726r10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/cen.13735","article-title":"Assessment and management of bone health in women with oestrogen receptor-positive breast cancer receiving endocrine therapy: position statement of the Endocrine Society of Australia, the Australian and New Zealand Bone & Mineral Society, the Australasian Menopause Society and the Clinical Oncology Society of Australia.","volume":"89","author":"Grossmann","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"31","key":"zoi260726r11","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1200\/JCO.19.01696","article-title":"Management of osteoporosis in survivors of adult cancers with nonmetastatic disease: ASCO clinical practice guideline.","volume":"37","author":"Shapiro","year":"2019","journal-title":"J Clin Oncol"},{"key":"zoi260726r12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2021.100355","article-title":"Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer.","volume":"28","author":"Waqas","year":"2021","journal-title":"J Bone Oncol"},{"issue":"12","key":"zoi260726r13","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.annonc.2020.07.019","article-title":"Bone health in cancer: ESMO Clinical Practice Guidelines.","volume":"31","author":"Coleman","year":"2020","journal-title":"Ann Oncol"},{"key":"zoi260726r14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2020.100311","article-title":"Guidance for the assessment and management of prostate cancer treatment-induced bone loss: a consensus position statement from an expert group.","volume":"25","author":"Brown","year":"2020","journal-title":"J Bone Oncol"},{"key":"zoi260726r15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","article-title":"American Association of Clinical Endocrinologists\/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis\u20142020 update.","volume":"26","author":"Camacho","year":"2020","journal-title":"Endocr Pract"},{"issue":"29","key":"zoi260726r16","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1200\/JCO.20.00434","article-title":"Bone mineral density and FRAX score may not predict fracture risk in patients with cancer undergoing hormone deprivation therapies.","volume":"38","author":"Dalla Volta","year":"2020","journal-title":"J Clin Oncol"},{"issue":"11","key":"zoi260726r17","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s40618-019-01063-0","article-title":"Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors.","volume":"42","author":"Catalano","year":"2019","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"zoi260726r18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252487","article-title":"Association between obesity and risk of fracture, bone mineral density and bone quality in adults: a systematic review and meta-analysis.","volume":"16","author":"Turcotte","year":"2021","journal-title":"PLoS One"},{"issue":"10","key":"zoi260726r19","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/jbmr\/zjaf091","article-title":"Body mass index and subsequent fracture risk: a meta-analysis to update FRAX.","volume":"40","author":"Harvey","year":"2025","journal-title":"J Bone Miner Res"},{"issue":"4","key":"zoi260726r20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1365-2265.1980.tb02721.x","article-title":"Abnormal sex steroid secretion and binding in massively obese women.","volume":"12","author":"Kopelman","year":"1980","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"zoi260726r21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/cob.12240","article-title":"Complex interplay among adiposity, insulin resistance and bone health.","volume":"8","author":"Ma","year":"2018","journal-title":"Clin Obes"},{"key":"zoi260726r22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nutres.2016.12.010","article-title":"Obesity is a concern for bone health with aging.","volume":"39","author":"Shapses","year":"2017","journal-title":"Nutr Res"},{"issue":"2","key":"zoi260726r23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/ejendo\/lvae086","article-title":"Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies.","volume":"191","author":"Birtolo","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"zoi260726r24","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41391-021-00474-6","article-title":"Is BMI a reliable prognostic parameter in metastatic prostate cancer patients?","volume":"25","author":"Caramella","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"22","key":"zoi260726r25","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.3390\/nu14224848","article-title":"New BMI cut-off points for obesity in middle-aged and older adults in clinical nutrition settings in Italy: a cross-sectional study.","volume":"14","author":"Di Renzo","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"zoi260726r26","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.50950","article-title":"Fat body mass and vertebral fracture progression in women with breast cancer.","volume":"7","author":"Cosentini","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"20","key":"zoi260726r27","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"12","key":"zoi260726r28","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.","volume":"12","author":"Vandenbroucke","year":"2014","journal-title":"Int J Surg"},{"issue":"4","key":"zoi260726r29","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.clnu.2021.11.014","article-title":"Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement.","volume":"41","author":"Donini","year":"2022","journal-title":"Clin Nutr"},{"issue":"6","key":"zoi260726r30","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/s41366-019-0516-8","article-title":"Defining cutoffs to diagnose obesity using the relative fat mass (RFM): association with mortality in NHANES 1999-2014.","volume":"44","author":"Woolcott","year":"2020","journal-title":"Int J Obes (Lond)"},{"key":"zoi260726r31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2025.100694","article-title":"Management of aromatase inhibitor-associated bone loss (AIBL) in women with hormone-sensitive breast cancer: An updated joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG.","volume":"53","author":"Hadji","year":"2025","journal-title":"J Bone Oncol"},{"issue":"5","key":"zoi260726r33","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1177\/03008916251367339","article-title":"The use of bone-modifying agents in early breast cancer: AIOM guidelines update and perspectives.","volume":"111","author":"Zambelli","year":"2025","journal-title":"Tumori"},{"issue":"4","key":"zoi260726r35","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1214\/ss\/1177011136","article-title":"Inference from iterative simulation using multiple sequences.","volume":"7","author":"Gelman","year":"1992","journal-title":"Stat Sci"},{"key":"zoi260726r36","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1682231","article-title":"Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan.","volume":"16","author":"Lee","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"zoi260726r37","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.11080","article-title":"Association of fat body mass with vertebral fractures in postmenopausal women with early breast cancer undergoing adjuvant aromatase inhibitor therapy.","volume":"2","author":"Pedersini","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"10","key":"zoi260726r38","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s11912-023-01447-9","article-title":"Role of body composition in the prediction of skeletal fragility induced by hormone deprivation therapies in cancer patients.","volume":"25","author":"Dalla Volta","year":"2023","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"zoi260726r39","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s40618-023-02174-5","article-title":"Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors.","volume":"47","author":"Antonini","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"zoi260726r40","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s00223-022-01011-w","article-title":"Real-world effectiveness of denosumab and bisphosphonates on risk of vertebral fractures in women with breast cancer undergoing treatment with aromatase inhibitors.","volume":"111","author":"Mazziotti","year":"2022","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"zoi260726r41","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00223-023-01150-8","article-title":"Narrative review of effects of glucagon-like peptide-1 receptor agonists on bone health in people living with obesity.","volume":"114","author":"Herrou","year":"2024","journal-title":"Calcif Tissue Int"},{"key":"zoi260726r42","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2024.103818","article-title":"Clinical significance of serum estradiol monitoring in women receiving adjuvant aromatase inhibitor for hormone receptor-positive early breast cancer.","volume":"78","author":"Dai","year":"2024","journal-title":"Breast"},{"key":"zoi260726r43","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1231527","article-title":"Association of the visceral adiposity index with femur bone mineral density and osteoporosis among the U.S. older adults from NHANES 2005-2020: a cross-sectional study.","volume":"14","author":"Sun","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"18","key":"zoi260726r44","doi-asserted-by":"publisher","first-page":"6239","DOI":"10.1080\/10408398.2023.2166456","article-title":"Associations of abdominal obesity with different types of bone fractures in adults: a systematic review and dose-response meta-analysis of prospective cohort studies.","volume":"64","author":"Zahedi","year":"2024","journal-title":"Crit Rev Food Sci Nutr"},{"key":"zoi260726r45","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1506841","article-title":"Association between a body shape index and bone mineral density in middle-aged and elderly adults: a retrospective analysis of NHANES 2005-2018.","volume":"16","author":"Wang","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"zoi260726r34","doi-asserted-by":"crossref","DOI":"10.1201\/b12208","volume-title":"Joint Models for Longitudinal and Time-to-Event Data: With Applications in R","author":"Rizopoulos","year":"2012"},{"key":"zoi260726r32","unstructured":"Agenzia Italiana del Farmaco. Nota 79: prescrizione dei farmaci per l\u2019osteoporosi. September 13, 2025. Accessed May 13, 2026. https:\/\/www.aifa.gov.it\/documents\/20142\/1728074\/nota-79.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2852273\/schivardi_2026_oi_260726_1784825341.75253.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:30:27Z","timestamp":1785425427000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2852273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.26450","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]}}}